Home > Annual Financials > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS Financial Statement Analysis
[BOM: 544319|NSE : SENORES]

The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .
The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 96.93 % YoY.
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 544319|NSE : SENORES]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹398 Cr₹215 Cr₹353 Cr₹14 Cr₹14 Cr
Expenses ₹309 Cr₹173 Cr₹227 Cr₹12 Cr₹12 Cr
Operating Profit (Excl OI) ₹90 Cr₹42 Cr₹127 Cr₹1.95 Cr₹1.95 Cr
Other Income ₹19 Cr₹2.82 Cr₹37 Cr₹0.46 Cr₹0.46 Cr
Interest ₹22 Cr₹9.45 Cr₹21 Cr₹0.57 Cr₹0.57 Cr
Depreciation ₹17 Cr₹10.00 Cr₹18 Cr₹0.71 Cr₹0.71 Cr
Profit Before Tax ₹71 Cr₹25 Cr₹124 Cr₹1.14 Cr₹1.14 Cr
Profit After Tax ₹58 Cr₹33 Cr₹84 Cr₹0.99 Cr₹0.99 Cr
Consolidated Net Profit ₹59 Cr₹31 Cr₹84 Cr₹0.99 Cr₹0.99 Cr
Earnings Per Share (Rs)₹25.05₹12.72₹10.31₹8.59₹1.13
PAT Margin (%)19.2114.6515.2523.866.99
ROE(%)14.1411.7826.1920.552.71
ROCE(%)15.6611.9412.3118.563.36
Total Debt/Equity(x)0.350.391.221.340.39

Key Financials

Market Cap : ₹ 6,863.6 Cr
Revenue (TTM) : ₹ 691.7 Cr
Net Profit(TTM) : ₹ 130.8 Cr
EPS (TTM) : ₹ 28.4
P/E (TTM) : 52.5

Industry Peers & Returns1W1M1Y
SENORES PHARMACEUTICALS 3.9% 0.9% 114.8%
SUN PHARMACEUTICAL INDUSTRIES -1.9% -3.7% 18.9%
DIVIS LABORATORIES 2.6% 11.1% 56%
TORRENT PHARMACEUTICALS 0.2% 1.3% 38%
CIPLA -1.5% -6.4% -12.3%
DR REDDYS LABORATORIES -1% -5.1% -8.1%
MANKIND PHARMA -3.4% -6.6% -10.1%
LUPIN -2% -8.2% 8.9%
ZYDUS LIFESCIENCES -0.5% -4.3% 13.6%


SENORES PHARMACEUTICALS Revenues
[BOM: 544319|NSE : SENORES]

Y-o-Y

85.65 %

5 Yr CAGR

130.25 %

Years Revenues % Change
Mar2026 ₹398 Cr
85.65
Mar2025 ₹215 Cr
-39.29
Mar2024 ₹353 Cr
2,393.79
Mar2023 ₹14 Cr
0.00
Mar2022 ₹14 Cr -


SENORES PHARMACEUTICALS Operating Profit
[BOM: 544319|NSE : SENORES]

Y-o-Y

115.78 %

5 Yr CAGR

160.36 %

Years Operating Profit % Change
Mar2026 ₹90 Cr
115.78
Mar2025 ₹42 Cr
-67.19
Mar2024 ₹127 Cr
6,390.78
Mar2023 ₹1.95 Cr
0.00
Mar2022 ₹1.95 Cr -

Operating Margins
Y-o-Y

16.20 %

5 Yr CAGR

13.07 %

Years Operating Margin% % Change
Mar2026 22.52%
16.20
Mar2025 19.38%
-45.94
Mar2024 35.85%
160.16
Mar2023 13.78%
0.00
Mar2022 13.78% -

SENORES PHARMACEUTICALS Profit After Tax
[BOM: 544319|NSE : SENORES]

Y-o-Y

86.14 %

5 Yr CAGR

177.26 %

Years Profit After Tax % Change
Mar2026 ₹59 Cr
86.14
Mar2025 ₹31 Cr
-62.69
Mar2024 ₹84 Cr
8,409.59
Mar2023 ₹0.99 Cr
0.00
Mar2022 ₹0.99 Cr -

PAT Margins
Y-o-Y

31.13 %

5 Yr CAGR

28.75 %

Years PAT Margin(%) % Change
Mar2026 19.21 %
31.13
Mar2025 14.65 %
-3.93
Mar2024 15.25 %
-36.09
Mar2023 23.86 %
241.34
Mar2022 6.99 % -

SENORES PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 544319|NSE : SENORES]

Y-o-Y

96.93 %

5 Yr CAGR

116.99 %

Years EPS % Change
Mar2026 ₹25
96.93
Mar2025 ₹13
23.38
Mar2024 ₹10
20.02
Mar2023 ₹8.59
660.18
Mar2022 ₹1.13 -

SENORES PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 544319|NSE : SENORES]

Y-o-Y

31.16 %

5 Yr CAGR

46.93 %

Years ROCE % Change
Mar2026 15.66%
31.16
Mar2025 11.94%
-3.01
Mar2024 12.31%
-33.67
Mar2023 18.56%
452.38
Mar2022 3.36% -

SENORES PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹1,488.9
Current MarketCap: ₹ 6,863.6 Cr
Updated EOD on :Sep 09,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

3.9%

0.9%

114.8%

SENSEX

-2.4%

-4.8%

-7.2%

SENORES PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 0.5% 0.6% 16.4%
No NSE index found

You may also like the below Video Courses


FAQ about SENORES PHARMACEUTICALS Financials


How the annual revenues of SENORES PHARMACEUTICALS have changed ?

The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .

How the Earnings per Share (EPS) of SENORES PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 96.93 % YoY .